Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 14
Submit an article Journal homepage
672
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel

Shalev Frieda Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1306-222X
ORCID Icon,
Roni Shouvala Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel;c Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA;d Weill Cornell Medical College, New York, NY, USAORCID Iconhttps://orcid.org/0000-0001-9827-8032
ORCID Icon,
Nira Varda-Bloome Hematology Laboratory, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Michal J. Besserf Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel-Aviv, Israel;g Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Ronit Yerushalmia Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
,
Noga Shem-Tova Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
,
Ivetta Danyleskoa Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
,
Elad Jacobyb Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel;h Department of Pediatric Hematology-Oncology, Safra Children’s Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Shlomit Teihmane Hematology Laboratory, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Orit Itzhakig Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel
,
Joshua A. Feini University of Connecticut Medical Center, Farmington, CT, USA
,
Meirav Kedmia Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel;j The Mina and Everard Goodman faculty of life sciences, Bar Ilan University, Ramat Gan, Israel
,
Avichai Shimonia Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
,
Arnon Naglera Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
&
Abraham Avigdora Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel;b Sackler School of Medicine, Tel Aviv University, Tel-Aviv, IsraelORCID Iconhttps://orcid.org/0000-0002-7448-869X
ORCID Icon show all
Pages 3385-3393 | Received 01 Jul 2022, Accepted 30 Aug 2022, Published online: 16 Sep 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shalev Fried, Eden Shkury, Orit Itzhaki, Inbal Sdayoor, Ronit Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, Elad Jacoby, Roni Shouval, Meirav Kedmi, Ronit Marcus, Arnon Nagler, Avichai Shimoni & Abraham Avigdor. (2023) Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma. Leukemia & Lymphoma 0:0, pages 1-8.
Read now

Articles from other publishers (1)

. (2023) Tisagenlecleucel. Reactions Weekly 1946:1, pages 515-515.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.